FDA Approves A New Covid-19 Booster, Targeting XBB.1.5
New Covid-19 vaccines employ the same mRNA-based technology as previously approved versions of the vaccines. However, they target the XBB.1.5 omicron subvariant.
New Covid-19 vaccines employ the same mRNA-based technology as previously approved versions of the vaccines. However, they target the XBB.1.5 omicron subvariant.